Skip to content
DataLookout
Menu

NCT05319509

Pilot Study of Virtual Reality Therapy for Students With Anxiety

StatusTerminated
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: funding issues Show 6 more changesShow less
    • Eligibility criteria expanded, about 6 words
    • Primary endpoints: details revised at 1 of 11 entries
    • Final enrollment: 10 participants (planned 100)
    • Primary completion date changed from estimate of Apr 1, 2027 to Sep 21, 2026
    • Secondary endpoints: details revised at 3 of 4 entries
    • Site details revised
  2. Notable Primary completion date: Apr 1, 2024 to Apr 1, 2027
    • Study completion date: Aug 1, 2024 to Aug 1, 2027
    v4
  3. Notable Primary completion date: Apr 1, 2023 to Apr 1, 2024
    • Study completion date: Apr 1, 2023 to Aug 1, 2024
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Change in state anxiety as assessed by the Liebowitz Social Anxiety Scale-Self Report version (LSAS-SR)
Timeframe: before first session in week 1, before third session in week 2 and before sixth session in week 3
Change in depressive symptoms as assessed by score on the Patient Health Questionnaire-4 (PHQ-4)
Timeframe: Baseline(before the first session in week 1)
Change in anxiety related behaviors such as rate of speech
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in anxiety related behaviors such as volume of speech
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in anxiety related behaviors such as Negative self-talk
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in anxiety related behaviors such as Utterances about experience
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in anxiety related behaviors such as Laughter
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in Psychomotor agitation such as pacing
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in Psychomotor agitation such as Fidgeting
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in Psychomotor agitation such as Rubbing hands/neck/head
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Change in physiology such as perspiration
Timeframe: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

Secondary (4)

Change in self-reported academic performance as assessed by the Motivated Strategies for Learning Questionnaire (MSLQ)
change in feasibility as assessed by the rating on a short questionnaire
Change in acceptability as assessed by the rating on a short questionnaire
Change in perceived presence in the virtual environment (as indicated by continuous score on the Igroup Presence Questionnaire (IPQ)

Arms and interventions

gameChangeExperimental

Devices: gameChange

Sites

1 site in 1 country

  • The University of Texas Health Science Center at HoustonHouston, Texas, United States